FDA grants priority review to brigatinib for first-line treatment of ALK -positive lung cancer - Healio
FDA grants priority review to brigatinib for first-line treatment of ALK -positive lung cancer Healio
Oncology: The disease, dynamics & challenges of market research
inoperable small cell lung cancer :: Article Creator Inoperable Lung Cancer Inoperable lung cancer is a tumor that surgery can't treat. This might be because the cancer is in a hard-to-reach spot or for other reasons, like if it's spread outside your lungs. It's also called unresectable lung cancer. Just because you can't have surgery doesn't mean you can't do anything about the cancer. Treatments like radiation, chemotherapy, targeted therapy, and immunotherapy can fight it, even when an operation isn't an option. There are two main types of lung cancer, based on the size and other factors of the affected cells: Non-small-cell lung cancer (NSCLC). Up to 85% of lung cancer cases are this kind. It has three subtypes: Adenocarcinoma. This starts in cells that make things like mucus. It's often found in the outer parts of your lung, many times before it has spread. Squamous cell carcinoma. This begins in th...
Comments
Post a Comment